Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Accrued Expenses and Other Current Liabilities

v3.20.2
Note 3 - Accrued Expenses and Other Current Liabilities
9 Months Ended
Sep. 30, 2020
Notes to Financial Statements  
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]

3. Accrued Expenses and Other Current Liabilities

 

Accrued expenses and other current liabilities consist of the following components (in thousands): 

  

   

September 30, 2020

   

December 31, 2019

 

Accrued chemistry manufacturing and control costs

  $ 1,086     $ 49  

Accrued clinical activities

    311       93  

Accrued payroll and bonuses

    247       436  

Operating lease liability - current

    114       103  

Related party payable

    99       99  

Accrued license fees and sponsored research agreements

    95       201  

Accrued legal, regulatory, and professional

    87       272  

Accrued other

    56       164  

Total accrued expenses and other current liabilities

  $ 2,095     $ 1,417